Almac doubles drug product development capacity; Icon, Tigermed look for Big Data solutions;

> Almac has doubled its drug product development capacity with a new non-GMP formulation facility and two analytical laboratories at its U.K. headquarters. News

> Chinese CRO Tigermed is reaching out to Oracle ($ORCL) to manage the wealth of data generated through its clinical trials, using its Oracle Health Sciences InForm platform to track and verify results. More

> Icon ($ICLR) is teaming up with Cerner, an electronic health records specialist, planning to use the company's software to manage study data. Article

> Drug delivery contractor OctoPlus has inked a Master Service Agreement with Sanofi ($SNY) that covers the development of undisclosed new formulations. Story

> Lonza is looking to double its antibody drug conjugate manufacturing in an effort to reverse the fortunes of one of its Swiss plants. Item

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

WCG is continuing its buyout run after acquiring clinical trial solutions firm Trifecta Clinical.

London-based uMed has raised nearly $4.8 million from U.K. and U.S. VCs to help healthcare providers participate in more clinical studies.

Amgen has teamed up with cloud-based trial solutions firm Reify Health to help boost patients into its drug studies.